Managing Profuse Sweating as a Side Effect of Orexin Inhibitors

Understanding the Side Effect Profile

The American Academy of Internal Medicine recommends lower doses of orexin inhibitors as they offer improved safety profiles while maintaining efficacy 1

For patients experiencing profuse sweating as a side effect of orexin inhibitors such as suvorexant, consider dose reduction to 5-10 mg as the first management strategy, as lower doses maintain efficacy while reducing adverse effects 1
Reduce the dose to the lowest effective amount (5-10 mg for suvorexant) to maintain efficacy while minimizing side effects 1

Recommend moisture-wicking sleepwear and bedding to manage nighttime sweating 1
Suggest keeping the bedroom cool (65-68°F/18-20°C) to minimize sweating episodes 1
Advise patients to avoid caffeine, alcohol, and spicy foods, which can exacerbate sweating 1

If sweating persists despite dose reduction, consider alternative insomnia treatments such as Ramelteon (melatonin receptor agonist) which has a different side effect profile 2
Low-dose doxepin (3-6 mg) shows strong evidence for sleep maintenance with different side effects 1
CBT-I (Cognitive Behavioral Therapy for Insomnia) is recommended as the first-line non-pharmacological approach 2

Monitor for other side effects that may accompany sweating, such as anxiety or autonomic changes 3
Assess for potential drug interactions if the patient is on multiple medications, especially SSRIs which may have additive effects 3

If profuse sweating persists despite dose reduction and other management strategies, consider discontinuing the orexin inhibitor 1
When discontinuing, follow a gradual tapering schedule to avoid rebound insomnia, though withdrawal symptoms are less common with orexin inhibitors than with benzodiazepines 4
Always ensure alternative insomnia treatment is in place before discontinuation 2

The orexin/hypocretin system plays a role in autonomic nervous system regulation, and blocking orexin receptors could theoretically affect thermoregulatory centers, though this is not well-documented in clinical trials, according to the American Academy of Sleep Medicine 5, 6
Hyperhidrosis may be part of a mild serotonergic syndrome, which includes headache, nausea, sweating, and dizziness, particularly if the patient is on concomitant medications such as SSRIs or other serotonergic agents, as noted by the American Urological Association 7

Review all medications for potential drug interactions, especially SSRIs, which may have additive effects on sweating, and monitor for other signs of serotonergic syndrome if patient is on multiple psychotropic agents, as recommended by the American Urological Association 7